Profund Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $538K | Sell |
24,807
-1,204
| -5% | -$26.1K | 0.02% | 446 |
|
|
2025
Q1 | $631K | Sell |
26,011
-1,402
| -5% | -$34K | 0.03% | 410 |
|
|
2024
Q4 | $572K | Sell |
27,413
-1,705
| -6% | -$35.6K | 0.02% | 445 |
|
|
2024
Q3 | $579K | Sell |
29,118
-9,842
| -25% | -$196K | 0.02% | 471 |
|
|
2024
Q2 | $603K | Sell |
38,960
-41,182
| -51% | -$638K | 0.02% | 444 |
|
|
2024
Q1 | $1.28M | Buy |
80,142
+18,578
| +30% | +$296K | 0.05% | 294 |
|
|
2023
Q4 | $1.03M | Sell |
61,564
-27,895
| -31% | -$469K | 0.04% | 322 |
|
|
2023
Q3 | $1.05M | Sell |
89,459
-43,209
| -33% | -$505K | 0.06% | 272 |
|
|
2023
Q2 | $1.78M | Buy |
132,668
+42,534
| +47% | +$572K | 0.1% | 166 |
|
|
2023
Q1 | $1.49M | Buy |
90,134
+77,524
| +615% | +$1.29M | 0.09% | 184 |
|
|
2022
Q4 | $235K | Buy |
12,610
+55
| +0.4% | +$1.02K | 0.02% | 803 |
|
|
2022
Q3 | $161K | Buy |
+12,555
| New | +$161K | 0.01% | 849 |
|